Bittium Biosignals
A high-tech company specializing in Secure Connectivity, R&D Services, Tactical Communications and Medical Technologies.
Launch date
Employees
Market cap
AUD398m
Enterprise valuation
AUD427m (Public information from Sep 2024)
Share price
€6.46 BITTI.HE
Company register number 1855598-7
Oulu North Ostrobothnia (HQ), Kuopio North Savo (founding location)
Financials
Estimates*
EUR | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | 75.2m | 78.4m | 86.9m | 82.5m | 75.2m | 80.5m | 96.4m |
% growth | - | 4 % | 11 % | (5 %) | (9 %) | 7 % | 20 % |
EBITDA | 13.9m | 13.4m | 13.3m | 10.7m | 5.1m | - | - |
% EBITDA margin | 18 % | 17 % | 15 % | 13 % | 7 % | - | - |
Profit | 7.6m | 2.2m | 3.3m | <1m | (5.4m) | - | - |
% profit margin | 10 % | 3 % | 4 % | - | (7 %) | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | €50.0k | Grant | |
* | N/A | N/A | Post IPO Equity |
Total Funding | AUD85.0k |
Recent News about Bittium Biosignals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Bittium Biosignals
EditACQUISITION by Bittium Biosignals Nov 2022